Cargando…
晚期非小细胞肺癌初始治疗后再次应用EGFR-TKI的疗效观察
BACKGROUND AND OBJECTIVE: The epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) shows favorable antitumor activity against chemorefractory non-small cell lung cancer (NSCLC). However, patients with advanced NSCLC have limited treatment options available if they are refractory to...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999659/ https://www.ncbi.nlm.nih.gov/pubmed/21426670 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.03.22 |